Standardisation and improvement of generic pre-analytical tools and procedures for in-vitro diagnostics (SPIDIA)
SPIDIA is a 4-year project, funded by the European Union FP7 programme to the value of 9 million Euros, which brings together a consortium of 16 leading academic institutions, international organisations and life sciences companies.
AimsThe project is coordinated by QIAGEN GmbH and aims to tackle the standardisation and improvement of pre-analytical procedures for in-vitro diagnostics. The proposed research and standardisation activities cover all steps from creation of evidence-based guidelines to creation of tools for the pre-analytical phase to testing and optimisation of these tools through the development of novel assays and biomarkers.
MethodsCesagen’s input is via membership of the Ethics Committee to discuss issues such as sample handling and storage.
Further informationFor further information, please visit the SPIDIA website.